Decrease (-) Restore Default Increase (+)

Clinical Trials

Topic   Metastatic Non-Small Cell Lung Cancer
Title   A non-interventional, stated preference study to examine patient preferences for tyrosine kinase inhibitor (TKI) treatment attributes among adults with epidermal growth factor receptor positive (EGFR+) metastatic non-small cell lung cancer (NSCLC)
Summary   This is a non-interventional study. All participants will be emailed a URL link that will lead to an online survey. The study is gathering information about treatment preference for patients that are receiving tyrosine kinase inhibitor (TKI) treatment. This survey is for adults with epidermal growth factor receptor positive (EGFR+) metastatic non-small cell lung cancer.
Description   Patient will sign a consent form. Participants will have up to 14 days to complete the online survey from the time the survey link is received. Once the link has been opened and consent has been obtained, participants will have up to 48 hours to complete it.

The preference survey will have a series of hypothetical treatment options. Patients are asked to select the option they prefer the most. Socio-demographic and clinical characteristics also will be collected within the survey. The online survey will take approximately 30 minutes to complete. Each participant can only complete the survey once. Participants will be compensated a one-time payment of $30 for their time.
IRB Number   17336
Inclusion/Notes   To be eligible for this study, patients must meet several criteria, including but not limited to the following:

  • This study is for patients age 19 and older.
  • Must have had EGFR + NSCLC
  • Adequate written and oral fluency in English
  • Willing and able to complete an online computer survey to answer questions about treatment experiences and preferences
Status   Open
Start Date   11/01/2017
Principal Name   Jeffrey Schneider, MD
Contact Name   Lisa Chen, RN
Email   lchen2@nyuwinthrop.org
Fax   516-663-1871
Current Trial Type   Non-Interventional
Phone   516-663-1081
Alternate Phone   516-663-1081